Fortress Biotech, Inc. - 31 Mar 2025 Form 4 Insider Report for AVENUE THERAPEUTICS, INC. (ATXI)

Role
10%+ Owner
Signature
/s/ Samuel Berry, Attorney-in-Fact
Issuer symbol
ATXI
Transactions as of
31 Mar 2025
Net transactions value
$0
Form type
4
Filing time
02 Apr 2025, 16:05:13 UTC
Previous filing
27 Feb 2025
Next filing
03 Jun 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATXI COMMON STOCK, PAR VALUE $0.0001 Award $0 +33,724 +11% $0.000000 328,524 31 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer is required to grant to the Reporting Person an equity fee in shares of the Issuer's Common Stock equal to 2.5% of the gross amount of any debt or equity financing consummated by the Issuer. These shares were granted by the Issuer to the Reporting Person following the receipt of proceeds by the Issuer upon the exercise of warrants previously issued by the Issuer.